康西哥 CNC 深 滬
交易中 06-24 11:03:50 美东时间
62.10
-1.040
-1.65%
華盛通- 最 高63.96
- 今 開63.82
- 成交量 93.85万股
- 最 低 61.715
- 昨 收 63.14
- 總市值 3066.48万
- 52周最高 66.55
- 市盈率 靜 --
- 換手率 190.06%
- 52周最低 25.075
- 委 比 -64.48%
- 總股本 0.00亿
- 歷史最高 98.53
- 量 比 0.70
- 振 幅 3.56%
- 歷史最低 12.13
- 每 手 1
- 風險率 10.02%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 美银上调美光科技目标价从950美元升至1500美元，上调迈威尔科技目标价从240美元升至365美元
今日重点评级关注：摩根士丹利：维持杜邦"标配"评级，目标价从52美元升至156美元；蒙特利尔银行：维持Taysha Gene Therapies"跑赢大市"评级，目标价从10美元升至14美元
今天 14:08
Centene Adds Veteran Executive Lauren Tyler to Board
Centene ( ($CNC) ) has issued an update. Centene Corporation announced that eff...
06-23 05:59
瑞银拆解医疗AI红利：AI难以成为险企“护城河”，医院反成最大赢家
瑞银近日发布报告指出，人工智能(AI)正逐步成为医疗健康领域的底层核心技术，但本轮技术变革的最大受益者并非医疗保险公司，医院反而有望依托AI构筑更稳固的长期竞争...
06-22 08:48
If You Invested $100 In Centene Stock 20 Years Ago, You Would Have This Much Today
Centene (NYSE:CNC) has outperformed the market over the past 20 years by 2.95% on an annualized basis producing an average annual return of 12.35%. Currently, Centene has a market capitalization of $30.13 billion. Buying $100 In CNC: If an investor had bought $100 of CNC stock 20 years ago, it would...
06-19 05:30
Membership Slump Forces Health Giant Centene Into Staff Buyouts: Report
Centene Corp. (NYSE:CNC) will offer buyouts to most employees as the health insurer seeks to reduce costs following a significant decline in membership across its health plans. The U.S. insurer launched a voluntary separation program that will allow eligible employees to apply for buyouts. However, ...
06-17 01:53
美股大行评级 | 存储再获看多！美光、闪迪、西部数据获机构上调目标价；次新股Cerebras、Blackstone、EagleRock获多家机构首予买入平均
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.25美元升至5.5美元；Ascendiant Capital：维持Lucid Diagnostics"买入"评级，目标价从9美元升至9.25美元
06-09 11:33
JP Morgan Maintains Neutral on Centene, Raises Price Target to $60
JP Morgan analyst John Stansel maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $52 to $60.
06-08 23:19
美股大行评级 | 绩后暴跌，博通仍获11家大行上调目标价；CrowdStrike获21家大行集体上调目标价；Netskope、Veeva Systems惨遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持Vivos Therapeutics"买入"评级，目标价从3美元升至3.1美元；富国银行：维持Veeva Systems"超配"评级，目标价从317美元升至320美元
06-05 11:33
美股大行评级 | 瑞杰金融上调美光目标价从530美元升至1100美元；AMD、Arm、戴尔、英特尔等获多家机构上调目标价
今日重点评级关注：Ascendiant Capital：维持RenovoRx"买入"评级，目标价从13.5美元升至14美元；BTIG：维持Jade Biosciences"买入"评级，目标价从39美元升至74美元
06-02 16:25
Truist Securities Maintains Buy on Centene, Raises Price Target to $71
Truist Securities analyst David Macdonald maintains Centene (NYSE:CNC) with a Buy and raises the price target from $58 to $71.
06-01 22:00
